Fact Meets Function

This review article examines injectable peptide therapies, including BPC-157, relevant to orthopaedic and sports medicine practice, synthesizing existing evidence on mechanisms of action and clinical applications in musculoskeletal conditions. The review provides an overview of peptide-based therapeutic options and their potential role in orthopaedic treatment paradigms based on current literature. The evidence level is review article (synthesis of existing literature rather than original human clinical trials or animal model data).

This review article examines the current and potential applications of therapeutic peptides in orthopaedic medicine, including peptides such as BPC-157, discussing their mechanisms of action, clinical uses, and the obstacles to their development and implementation in orthopedic practice (Evidence level: Review). The article identifies key challenges in peptide therapeutics, such as stability, delivery mechanisms, and regulatory pathways, while also outlining future directions for research and clinical translation in orthopedic conditions. This represents a synthesis of existing literature rather than original research data from human clinical trials or animal studies.

This narrative review examined the evidence for BPC-157, a synthetic peptide derived from gastric juice, in promoting musculoskeletal tissue healing across multiple tissue types. The review identified promising preclinical findings in animal models showing potential benefits for tendon, ligament, muscle, and bone healing, though human clinical evidence remains limited and mostly anecdotal. The evidence base is primarily animal model and in vitro studies, with very few human clinical trials available to date.

This review article discusses BPC 157, a synthetic peptide, and its proposed mechanisms of action related to angiogenesis and nitric oxide regulation, responding to previous literature on the peptide’s multifunctional properties and potential medical applications. The authors address how BPC 157 may modulate the balance between protective and damaging actions of nitric oxide while promoting blood vessel formation. The evidence level is a review of existing literature rather than new primary research (review article).

This review article examined BPC 157, a synthetic peptide, and its proposed mechanisms of action related to angiogenesis and nitric oxide regulation in protecting against cellular damage while maintaining protective functions. The authors discuss BPC 157’s multifunctional properties and potential medical applications based on existing literature and patent data, suggesting the peptide may modulate harmful versus beneficial effects of nitric oxide and angiogenesis. The evidence presented is from a literature and patent review (evidence level: review article).

This review article examines BPC-157, a naturally occurring 15-amino acid peptide, and its proposed cytoprotective mechanisms in the gastrointestinal tract (evidence level: review). The authors discuss evidence suggesting BPC-157 may protect GIT tissues through multiple pathways, though the review synthesizes existing literature rather than presenting new experimental data. As a narrative review, this represents a lower evidence level compared to primary human clinical trials or controlled animal studies.

This systematic review examined the emerging evidence for BPC-157, a synthetic peptide, in treating orthopaedic and sports medicine conditions. The review synthesized findings from multiple studies (evidence level: review article incorporating human clinical, animal model, and in vitro research) and found that BPC-157 demonstrated potential benefits across various musculoskeletal injuries including tendon, ligament, muscle, and bone injuries, though the authors noted the need for more rigorous clinical trials to establish efficacy and safety in human populations.